
Cris Loiren Rodriguez
Supervisory Patent Examiner (ID: 13791, Phone: (571)272-4964 , Office: P/3732 )
| Most Active Art Unit | 3763 |
| Art Unit(s) | 3306, 3772, 1612, 3734, 3633, 2763, 3763, 3732, 3783 |
| Total Applications | 1175 |
| Issued Applications | 574 |
| Pending Applications | 326 |
| Abandoned Applications | 279 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5538714
[patent_doc_number] => 20090220519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'ANTI-IL-22RA ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 12/423699
[patent_app_country] => US
[patent_app_date] => 2009-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82949
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220519.pdf
[firstpage_image] =>[orig_patent_app_number] => 12423699
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/423699 | Methods of treatment using anti-IL-22RA antibodies | Apr 13, 2009 | Issued |
Array
(
[id] => 5479567
[patent_doc_number] => 20090202524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'PAI-1 EXPRESSION AND ACTIVITY INHIBITORS FOR THE TREATMENT OF OCULAR DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/421456
[patent_app_country] => US
[patent_app_date] => 2009-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5814
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20090202524.pdf
[firstpage_image] =>[orig_patent_app_number] => 12421456
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/421456 | PAI-1 EXPRESSION AND ACTIVITY INHIBITORS FOR THE TREATMENT OF OCULAR DISORDERS | Apr 8, 2009 | Abandoned |
Array
(
[id] => 5385772
[patent_doc_number] => 20090227017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'NUCLEIC ACIDS ENCODING RECEPTOR FOR IL-17 HOMOLOGOUS POLYPEPTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/417097
[patent_app_country] => US
[patent_app_date] => 2009-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 67815
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20090227017.pdf
[firstpage_image] =>[orig_patent_app_number] => 12417097
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/417097 | NUCLEIC ACIDS ENCODING RECEPTOR FOR IL-17 HOMOLOGOUS POLYPEPTIDES AND USES THEREOF | Apr 1, 2009 | Abandoned |
Array
(
[id] => 5379730
[patent_doc_number] => 20090191569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'Mammalian Cytokines; Related Reagents'
[patent_app_type] => utility
[patent_app_number] => 12/414267
[patent_app_country] => US
[patent_app_date] => 2009-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 21249
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191569.pdf
[firstpage_image] =>[orig_patent_app_number] => 12414267
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/414267 | IL-D80 polypeptides and IL-27 | Mar 29, 2009 | Issued |
Array
(
[id] => 5385771
[patent_doc_number] => 20090227016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/412796
[patent_app_country] => US
[patent_app_date] => 2009-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 75660
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20090227016.pdf
[firstpage_image] =>[orig_patent_app_number] => 12412796
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/412796 | Nucleic acids encoding receptor for IL-17 homologous polypeptides and therapeutic uses thereof | Mar 26, 2009 | Issued |
Array
(
[id] => 7499488
[patent_doc_number] => 20110262457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'MODULATION OF THE IMMUNE RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 12/933800
[patent_app_country] => US
[patent_app_date] => 2009-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13400
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20110262457.pdf
[firstpage_image] =>[orig_patent_app_number] => 12933800
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/933800 | MODULATION OF THE IMMUNE RESPONSE | Mar 18, 2009 | Abandoned |
Array
(
[id] => 6071220
[patent_doc_number] => 20110046071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'GLP-1 Receptor Agonists And Related Active Pharmaceutical Ingredients For Treatment Of Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/918512
[patent_app_country] => US
[patent_app_date] => 2009-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13435
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046071.pdf
[firstpage_image] =>[orig_patent_app_number] => 12918512
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/918512 | GLP-1 Receptor Agonists And Related Active Pharmaceutical Ingredients For Treatment Of Cancer | Mar 3, 2009 | Abandoned |
Array
(
[id] => 7530443
[patent_doc_number] => 07842665
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-30
[patent_title] => 'IL-17A and IL-17F antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/370309
[patent_app_country] => US
[patent_app_date] => 2009-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 70505
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/842/07842665.pdf
[firstpage_image] =>[orig_patent_app_number] => 12370309
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/370309 | IL-17A and IL-17F antagonists | Feb 11, 2009 | Issued |
Array
(
[id] => 4543280
[patent_doc_number] => 07959908
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-14
[patent_title] => 'Methods of treating viral infections using IL-21'
[patent_app_type] => utility
[patent_app_number] => 12/355650
[patent_app_country] => US
[patent_app_date] => 2009-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29283
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/959/07959908.pdf
[firstpage_image] =>[orig_patent_app_number] => 12355650
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/355650 | Methods of treating viral infections using IL-21 | Jan 15, 2009 | Issued |
Array
(
[id] => 5379311
[patent_doc_number] => 20090191150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'METHODS OF TREATING INFECTIONS USING IL-21'
[patent_app_type] => utility
[patent_app_number] => 12/352153
[patent_app_country] => US
[patent_app_date] => 2009-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29277
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191150.pdf
[firstpage_image] =>[orig_patent_app_number] => 12352153
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/352153 | METHODS OF TREATING INFECTIONS USING IL-21 | Jan 11, 2009 | Abandoned |
Array
(
[id] => 5392212
[patent_doc_number] => 20090209525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'ENABLING METHODS TO IDENTIFY ALLOSTERIC MODULATORS OF RECEPTOR ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/340393
[patent_app_country] => US
[patent_app_date] => 2008-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 19725
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209525.pdf
[firstpage_image] =>[orig_patent_app_number] => 12340393
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/340393 | ENABLING METHODS TO IDENTIFY ALLOSTERIC MODULATORS OF RECEPTOR ACTIVITY | Dec 18, 2008 | Abandoned |
Array
(
[id] => 5379375
[patent_doc_number] => 20090191214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'ANTI-HUMAN IL-21 MONOCLONAL ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 12/330334
[patent_app_country] => US
[patent_app_date] => 2008-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 38516
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191214.pdf
[firstpage_image] =>[orig_patent_app_number] => 12330334
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/330334 | Anti-human IL-21 monoclonal antibodies | Dec 7, 2008 | Issued |
Array
(
[id] => 6025847
[patent_doc_number] => 20110053865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'AMINO ACID SEQUENCES DIRECTED AGAINST HETERODIMERIC CYTOKINES AND/OR THEIR RECEPTORS AND POLYPEPTIDES COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/745052
[patent_app_country] => US
[patent_app_date] => 2008-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 133
[patent_figures_cnt] => 133
[patent_no_of_words] => 161006
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053865.pdf
[firstpage_image] =>[orig_patent_app_number] => 12745052
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/745052 | AMINO ACID SEQUENCES DIRECTED AGAINST HETERODIMERIC CYTOKINES AND/OR THEIR RECEPTORS AND POLYPEPTIDES COMPRISING THE SAME | Nov 26, 2008 | Abandoned |
Array
(
[id] => 5479518
[patent_doc_number] => 20090202475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Compositions and methods for treatment of microbial disorders'
[patent_app_type] => utility
[patent_app_number] => 12/291380
[patent_app_country] => US
[patent_app_date] => 2008-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 43607
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20090202475.pdf
[firstpage_image] =>[orig_patent_app_number] => 12291380
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/291380 | Compositions and methods for treatment of microbial disorders | Nov 6, 2008 | Abandoned |
Array
(
[id] => 5564106
[patent_doc_number] => 20090136959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Novel genes encoding proteins having prognostic, diagnostic preventive, therapeutic, and other uses'
[patent_app_type] => utility
[patent_app_number] => 12/288775
[patent_app_country] => US
[patent_app_date] => 2008-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 68
[patent_no_of_words] => 44544
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136959.pdf
[firstpage_image] =>[orig_patent_app_number] => 12288775
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/288775 | Novel genes encoding proteins having prognostic, diagnostic preventive, therapeutic, and other uses | Oct 22, 2008 | Abandoned |
Array
(
[id] => 5935911
[patent_doc_number] => 20110212076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'Viral Therapeutic'
[patent_app_type] => utility
[patent_app_number] => 12/682978
[patent_app_country] => US
[patent_app_date] => 2008-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20217
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20110212076.pdf
[firstpage_image] =>[orig_patent_app_number] => 12682978
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/682978 | Viral Therapeutic | Oct 14, 2008 | Abandoned |
Array
(
[id] => 6353271
[patent_doc_number] => 20100086548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'Use of Anti-IL-20 Antibody for Treating Rheumatoid Arthritis and Osteoporosis'
[patent_app_type] => utility
[patent_app_number] => 12/246715
[patent_app_country] => US
[patent_app_date] => 2008-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4482
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20100086548.pdf
[firstpage_image] =>[orig_patent_app_number] => 12246715
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/246715 | Use of anti-IL-20 antibody for treating osteoporosis | Oct 6, 2008 | Issued |
Array
(
[id] => 6353272
[patent_doc_number] => 20100086549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'Use of Anti-IL-20 Antibody for Treating Stroke'
[patent_app_type] => utility
[patent_app_number] => 12/246691
[patent_app_country] => US
[patent_app_date] => 2008-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3749
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20100086549.pdf
[firstpage_image] =>[orig_patent_app_number] => 12246691
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/246691 | Use of anti-IL-20 antibody for treating stroke | Oct 6, 2008 | Issued |
Array
(
[id] => 8063107
[patent_doc_number] => 20110245473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'Anti-IL-6 Receptor Antibody'
[patent_app_type] => utility
[patent_app_number] => 12/680112
[patent_app_country] => US
[patent_app_date] => 2008-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 60078
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20110245473.pdf
[firstpage_image] =>[orig_patent_app_number] => 12680112
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/680112 | Anti-IL-6 Receptor Antibody | Sep 25, 2008 | Abandoned |
Array
(
[id] => 5447206
[patent_doc_number] => 20090048432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'ANTI-IL-20 ANTIBODY AND ITS USE IN TREATING IL-20 ASSOCIATED INFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/238760
[patent_app_country] => US
[patent_app_date] => 2008-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7224
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048432.pdf
[firstpage_image] =>[orig_patent_app_number] => 12238760
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/238760 | Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases | Sep 25, 2008 | Issued |